HC Deb 17 July 1995 vol 263 c919W
Mr. Redmond

To ask the Secretary of State for Health what research and findings his Department has carried out into(a) anonymous sero-testing reference samples MIF chlamydia/herpes serology, (b) comparisons between MCS 9406 UK calcipotrol solution and capasal in scalp psoriasis, (c) the treatment of patients suffering from chronic schizophrenia with open label seroquel, (d) a random and double-blind study of safety and efficacy of Tiagbire versus Carbamazapine as monotherapy in patients with partial seizures and (e) an MRI study of early childhood convulsions; what were the findings; and if he will make a statement. [34082]

Mr. Bowis

No research has been carried out on anonymised serum samples for chlamydia or herpes simplex, but the Department co-ordinates an unlinked anonymous prevalence monitoring programme in England and Wales for human immunodeficiency virus.

Medicinal products for use in clinical trials are regulated under the Medicines Act 1968 and subsidiary legislation. The Medicines Control Agency acting on behalf of the Licensing Authority, keeps confidential records of all applications to conduct clinical trials. Information from these records cannot be disclosed in accordance with section 118 of the Medicines Act.

Back to